Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Jie Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2938-818X; OpenAlex author ID A5052880029. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers

Papers 8

  1. Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. Co-author DOI 10.1016/j.ejps.2021.106000↗
  2. RBM10 regulates human TERT gene splicing and inhibits pancreatic cancer progression. Co-author PMID 33520366↗
  3. First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis. Co-author DOI 10.2147/cmar.s162980↗
  4. [A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM]. Last author DOI 10.3760/cma.j.issn.0253-3766.2018.05.003↗
  5. Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Progno… Last author DOI 10.1155/2017/6495867↗
  6. Body mass index does not affect the survival of pancreatic cancer patients. Co-author DOI 10.3748/wjg.v23.i34.6287↗
  7. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer. Last author DOI 10.18632/oncotarget.12406↗
  8. [Expression and clinical significance of plasma small RNA in patients with pancreatic cancer]. Last author PMID 25030590↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yingtai Chen · 3 shared papers, 2016–2018 · strength 0.20
  2. Chengfeng Wang · 2 shared papers, 2017 · strength 0.14
  3. Jianwei Zhang · 2 shared papers, 2017–2018 · strength 0.14
  4. Wenjing Xiao · 1 shared paper, 2021 · strength 0.13
  5. Guimin Xia · 1 shared paper, 2021 · strength 0.13
  6. Qingfang Miao · 1 shared paper, 2021 · strength 0.13
  7. Dan Wang · 1 shared paper, 2021 · strength 0.13
  8. Xiaowei Wang · 1 shared paper, 2021 · strength 0.13
  9. Jun Hou · 1 shared paper, 2021 · strength 0.13
  10. Wei Yuan · 1 shared paper, 2018 · strength 0.12
  11. Yu Qi · 1 shared paper, 2017 · strength 0.08
  12. Shuisheng Zhang · 1 shared paper, 2018 · strength 0.08
  13. Chengfeng Wang · 1 shared paper, 2018 · strength 0.08
  14. Yuan Wei · 1 shared paper, 2016 · strength 0.06
  15. Jun Qi · 1 shared paper, 2016 · strength 0.06
  16. Xu Che · 1 shared paper, 2017 · strength 0.06
  17. Qinglong Jiang · 1 shared paper, 2017 · strength 0.06
  18. Dongbing Zhao · 1 shared paper, 2017 · strength 0.06
  19. Wenzheng Pan · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.